Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=43000b71-a187-4af2-ba6b-ba92ad0a6e1c Date 7/6/2015 Company Name Salsify Mailing Address 1 Winthrop Square 5th Floor Boston, MA 02110 USA Company Description Salsify provides cloud-based product content management solutions that make it easy for manufacturers, distributors, and retailers to exchange high-quality content that drives online results. The company was founded in late 2012 by a … Continue reading “Salsify Obtains $16,600,000 Series B Round”
Category: Boston
FDA Approves Vertex’s Two-Drug Combo For Cystic Fibrosis
[Updated 7/2/15, 2:55 p.m. See below.] The long-expected approval of Vertex Pharmaceuticals’ new combination drug for cystic fibrosis is finally here. The FDA approved the therapy regimen in a letter it sent to the Boston-based company Thursday. The drug’s approval was all but certain, and paves the way for potential billions of dollars in future sales. … Continue reading “FDA Approves Vertex’s Two-Drug Combo For Cystic Fibrosis”
Biogen Offers Up To $1 Billion for AGTC’s Ophthalmology Gene Therapy
Biogen’s revitalized interest in gene therapy continues with a deal the Cambridge, MA-based biotech giant announced this morning. Biogen has agreed to pay $124 million upfront (including about $30 million that came as an equity investment) and as much as $1.1 billion in future milestones to Gainesville, FL-based AGTC (NASDAQ: [[ticker:AGTC]]) for access to its … Continue reading “Biogen Offers Up To $1 Billion for AGTC’s Ophthalmology Gene Therapy”
Zagster Adds $3.5M to Expand Targeted Bike-Sharing Programs
Bikes are hot. The sharing economy is hot. So Zagster is hot. The Cambridge, MA-based bicycle-sharing company said today it has raised $3.5 million in new venture funding. The money comes from previous investors LaunchCapital, Fontinalis Partners, Clean Energy Venture Group, LaunchPad Venture Group, and Boston-area angel investors, as well as new investor Otter Consulting. … Continue reading “Zagster Adds $3.5M to Expand Targeted Bike-Sharing Programs”
XRpro Resurrects Icagen With Buy of Some Pfizer Ion Channel Assets
[Updated 7/2/15, 10:38 am. See below.] Finding new drugs can be challenging, time consuming, and expensive. But Cambridge, MA, drug discovery company XRpro Sciences believes it can make the process faster and more efficient, and it’s scooping up some North Carolina-based assets from Pfizer to do it. XRpro said today it has acquired drug discovery … Continue reading “XRpro Resurrects Icagen With Buy of Some Pfizer Ion Channel Assets”
Why I Killed Noncompetes at My Startup—And You Should, Too
There’s a battle brewing in Boston that every local startup founder and employee is closely watching, but the outcome will have implications far beyond Massachusetts. As our state legislature weighs several bills that would ban noncompete agreements, the New England Venture Capital Association (NEVCA) and many entrepreneurs, including myself, are arguing that the time is … Continue reading “Why I Killed Noncompetes at My Startup—And You Should, Too”
Cisco-OpenDNS Deal Shows Importance of DNS in Security, Dyn CEO Says
Cisco is paying $635 million for privately held OpenDNS, a company founded in 2005 by David Ulevitch, to further build out its cloud-based security business. But the deal is also a sign of the times, according to a prominent player in Web infrastructure. The purchase of San Francisco-based OpenDNS shows that there is still a … Continue reading “Cisco-OpenDNS Deal Shows Importance of DNS in Security, Dyn CEO Says”
Lantos Technologies Receives $1,468,840 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9700b92a-6f8a-48ed-a888-28c4a964a8c4 Date 7/2/2015 Company Name Lantos Technologies Mailing Address 201 Edgewater Drive Wakefield, MA 01880 USA Company Description Lantos Technologies is working to commercialize a 3D digital scanner capable of measuring ear canal shape and tissue compliance. This method will eliminate the uncertainties associated with manual fits, greatly improving the performance of … Continue reading “Lantos Technologies Receives $1,468,840 New Funding”
eTouches Garners $10,000,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7e9252ac-af0d-44e7-858d-53861520d53c Date 7/2/2015 Company Name eTouches Mailing Address 13 Marshall Street Norwalk, CT 06854 USA Company Description eTouches is a web-based software as a service (SaaS) provider to the $3.0 billion global, meeting and event technology marketplace. Website http://www.etouches.com Transaction Type Venture Equity Transaction Amount $10,000,000 Transaction Round Undisclosed Proceeds Purposes Proceeds … Continue reading “eTouches Garners $10,000,000 New Round”
Editas Medicine Hires Andrew Hack As CFO
Editas Medicine, of Cambridge, MA, has hired former hedge fund manager Andrew Hack as its chief financial officer, the company said this morning. Hack was most recently a portfolio manager at New York hedge fund Millennium Management, where he focused on biotechnology, pharmaceutical, and medical device companies. Hack got his start as the co-founder of … Continue reading “Editas Medicine Hires Andrew Hack As CFO”
Doctors See Big Cybersecurity Risks, Compliance as Key for Hospitals
Cybersecurity and healthcare IT are both burgeoning areas of business. Put them together and you have a volatile mix of emerging technologies, security and privacy risks, and regulatory requirements—but also a lot of opportunity for growth and improvements. It’s no surprise that doctors and hospital administrators are concerned with security. The healthcare industry is a … Continue reading “Doctors See Big Cybersecurity Risks, Compliance as Key for Hospitals”
Boston Coders Build “Yeah Buoii” to Prevent Illegal Fishing at High Sea
Coders may be used to hacking problems related to phishing, but one international contest that a group from Boston is hoping to win is tackling fishing itself. Four Bostonians have written algorithms and built a prototype buoy that is intended to detect, identify, and track ships on the high seas that enter “no-fish zones” in … Continue reading “Boston Coders Build “Yeah Buoii” to Prevent Illegal Fishing at High Sea”
Ex-Genzyme Chief Henri Termeer Signs On As Sarepta Advisor
Sarepta Therapeutics (NASDAQ: [[ticker:SRPT]]) of Cambridge, MA, has hired former Genzyme head Henri Termeer as an advisor as the company waits for word from FDA about its Duchenne muscular dystrophy treatment eteplirsen. As Xconomy reported Monday, Sarepta has asked the agency to start its final review of eteplirsen and decide whether the drug should come … Continue reading “Ex-Genzyme Chief Henri Termeer Signs On As Sarepta Advisor”
908 Devices Receives Series C Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=01345c7f-74c0-43c3-b893-03c348ced1bc Date 7/1/2015 Company Name 908 Devices Mailing Address 27 Drydock Ave 7th Floor Boston, MA 02210 USA Company Description At the heart of our systems are molecular traps a thousand times smaller than those in conventional mass spectrometers. These diminutive traps can operate much closer to atmospheric pressures and enable us … Continue reading “908 Devices Receives Series C Funding”
MachineMetrics Lands New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b5c00ee0-85ce-4cf1-a496-4f741edcb786 Date 7/1/2015 Company Name MachineMetrics Mailing Address 5 Strong Ave. Northampton, MA 01060 USA Company Description MachineMetrics opens a live view into production allowing workers to immediately react to manufacturing problems with real-time dashboards and notifications. Every second, data from each machine is stored securely and available for historical performance analysis … Continue reading “MachineMetrics Lands New Funding”
Pulmatrix Obtains $10,000,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c1ced2ac-8114-402d-9101-7057805b7d90 Date 7/1/2015 Company Name Pulmatrix Mailing Address 99 Hayden Avenue Lexington, MA 02421 USA Company Description Pulmatrix Inc. is a pharmaceutical company developing inhalable aerosols and enabling technologies that help control respiratory infectious disease and human-source airborne contamination. Website http://www.pulmatrix.com Transaction Type Venture Equity Transaction Amount $10,000,000 Transaction Round Undisclosed Proceeds … Continue reading “Pulmatrix Obtains $10,000,000 New Round”
SeeClickFix Receives $1,400,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=13d9b761-8d1f-421f-9b32-84f882a68105 Date 7/1/2015 Company Name SeeClickFix Mailing Address 746 Chapel St. New Haven, CT 06510 USA Company Description The company has developed an online service that makes it easy for individuals to report issues to their city government. Website http://www.seeclickfix.com Transaction Type Venture Equity Transaction Amount $1,400,000 Transaction Round Undisclosed Proceeds Purposes … Continue reading “SeeClickFix Receives $1,400,000 New Funding”
Amag Seeks New Chapter With $700M Cord Blood Registry Purchase
Amag Pharmaceuticals is trying to climb out of a midlife crisis, and it’s using acquisitions to do so. The Waltham, MA-based company split from long-time CEO Brian Pereira in 2011, a few weeks after its ill-fated attempt to merge with Allos Therapeutics (NASDAQ: [[ticker:ALTH]]) was voted down by shareholders. Amag (NASDAQ: [[ticker:AMAG]]) tried to move … Continue reading “Amag Seeks New Chapter With $700M Cord Blood Registry Purchase”
Five Obstacles That Impede Startup Innovation
If you’re building a startup, chances are that you’re aspiring to innovate – to create something new or do something differently. In fact, innovation and entrepreneurship go hand in hand. However, many startups unwittingly create obstacles that hamper innovation in their organization. What are some of those obstacles and how can you avoid them? Fear … Continue reading “Five Obstacles That Impede Startup Innovation”
Drafted Secures $2,500,000 Seed Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=fb0febd0-019c-4b1c-8768-a5ed0fe3ae55 Date 6/30/2015 Company Name Drafted Mailing Address 250 Summer Street Boston, MA 02210 USA Company Description Drafted, a mobile app focused on hiring via referrals, just launched out of stealth last month. Website http://www.drafted.us Transaction Type Venture Equity Transaction Amount $2,500,000 Transaction Round Seed Proceeds Purposes That funding will be used … Continue reading “Drafted Secures $2,500,000 Seed Round”
Celgene To Pay $1B For A Big Piece of Juno and T Cell Therapies
[Updated 6/29/15 7:00 pm. See below.] It seemed only a matter of time. One of biotech’s most aggressive deal makers, Celgene (NASDAQ: [[ticker:CELG]]) has struck a wide-ranging, billion-dollar partnership with one of biotech’s highest-profile drug makers, Juno Therapeutics (NASDAQ: [[ticker:JUNO]]), whose T cell therapies are part of a wave of products that could transform the … Continue reading “Celgene To Pay $1B For A Big Piece of Juno and T Cell Therapies”
Milestones of Innovation 9: Early Bird On Station
Fifty years ago, on June 28, 1965, an exotic device named Early Bird made it possible to transmit an uninterrupted live television show across the Atlantic from Europe to America or vice versa. This event, a landmark on the way to today’s interconnected world, happened less than 40 years after the first radio-telephone conversations between … Continue reading “Milestones of Innovation 9: Early Bird On Station”
BioMarin, Sarepta Update Positions In Race To Produce DMD Drug
The race to produce a drug to treat and perhaps cure one version of the rare Duchenne muscular dystrophy remains neck and neck. The entrants, BioMarin Pharmaceutical (NASDAQ: [[ticker:BMRN]]) and Sarepta Therapeutics (NASDAQ: [[ticker:SRPT]]), both had updates this morning in their final push to have their drugs approved by the FDA. BioMarin is a few … Continue reading “BioMarin, Sarepta Update Positions In Race To Produce DMD Drug”
FKA Atlas Has a New Name: Accomplice
One of Boston’s most active tech investing firms has a new name: FKA Atlas Venture is now Accomplice. No big announcement, and that’s the way the firm wants it. But the news ends months of speculation, as the tech side of Atlas Venture opened up a crowdsourcing contest in March to find its new name. … Continue reading “FKA Atlas Has a New Name: Accomplice”
Out of the Digital Health Fog, More Investments Are Coming in 2015
Venture capitalists have been talking up the rewards of digital health for some time now, and we are certainly putting our money where our mouth is. Record-breaking dollars continue to flow into health care IT startups. According to Rock Health, digital health saw over $4B in funding in 2014, more than doubling funding from 2013 … Continue reading “Out of the Digital Health Fog, More Investments Are Coming in 2015”
How Your Startup Can Run With Unicorns
Have you noticed those unicorns outside your office? Recently, there’s been an uptick in the all-important $1 billion “unicorn” valuation for startups in the tech industry. In the VC-funded startup community, the young companies receiving such valuations are in the media daily. When an entrepreneur considers her unicorn counterparts, it’s not hard to see why … Continue reading “How Your Startup Can Run With Unicorns”
New Amazon Fund Invests in Boston Hardware Firm Dragon Innovation
Dragon Innovation has been helping startups build their hardware products and raise funding since the Boston-based consultancy was founded in 2009. Now Dragon is adding a new focus when working with customers: voice. Dragon has received an undisclosed investment from a new fund created by Amazon, called the Alexa Fund, that invests in developer and … Continue reading “New Amazon Fund Invests in Boston Hardware Firm Dragon Innovation”
East Coast Biotech Roundup: Flagship, SQZ, Epizyme, IPOs & More
We’ve got a new site launch, local IPOs, and much more to dig through in this week’s roundup. But first, a programming note to you Xconomy readers: I’ll be away on a long break, returning in late July. In the meantime, stay tuned to Alex Lash and David Holley, who will take the lead on … Continue reading “East Coast Biotech Roundup: Flagship, SQZ, Epizyme, IPOs & More”
CoolChip Technologies Receives $603,611 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1026c2b5-d69c-4bcb-afe6-27f9b2b644c0 Date 6/26/2015 Company Name CoolChip Technologies Mailing Address 28 Dane Street Somerville, MA 02143 USA Company Description A rising need for low-cost, high-performance electronics cooling has given rise to commercial opportunities for technology innovations. Website http://www.coolchiptechnologies.com Transaction Type Venture Equity Transaction Amount $603,611 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were … Continue reading “CoolChip Technologies Receives $603,611 New Financing”
Celect Lands $5,000,000 Series A Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=15d892c7-112a-41c4-aa62-6801adea027e Date 6/26/2015 Company Name Celect Mailing Address 129 South Street 6th Floor Boston, MA 02111 USA Company Description What if you truly understood how your customers choose? What if you were able to identify how a given customer would likely react to an assortment of products? And based on this, how … Continue reading “Celect Lands $5,000,000 Series A Financing”
Bon Appetit: Seres And Its Microbiome Gut Treatment Notch $134M IPO
In the first big test of public investor appetite for the human microbiome, Seres Therapeutics (NASDAQ: [[ticker:MCRB]]) has priced shares tonight for its initial public offering at $18 each. The Cambridge, MA-based developer of bacteria-based treatments for serious gastrointestinal ailments sold 7.43 million shares to gross nearly $134 million. That sum is one-third more than … Continue reading “Bon Appetit: Seres And Its Microbiome Gut Treatment Notch $134M IPO”
Library High: San Francisco Public Library Offers Online Diploma With Cengage
[Corrected 6/26/15, 9:32 am. See below.] Educational technology is often cast as a solution to the high cost of a college degree, which Americans see as the essential gateway to reasonable earnings. But in San Francisco, which has one of the most highly educated populations in the country, more than 30,000 people over 25 lack … Continue reading “Library High: San Francisco Public Library Offers Online Diploma With Cengage”
Cybersecurity, DraftKings, OBJL, and 24M: A Boston Tech Roundup
In the run-up to summer, there have been a bunch of technology deals to catch up on around town. The news spans cybersecurity companies, business software, gaming, and energy—kind of a microcosm of New England tech innovation. —BitSight Technologies has just raised a $23 million Series B round from Comcast Ventures, Globespan Capital Partners, Flybridge … Continue reading “Cybersecurity, DraftKings, OBJL, and 24M: A Boston Tech Roundup”
On Eve of Seres IPO, A Rival Nonprofit Microbiome Treatment Expands
If you’re an investor anticipating the potential $100 million-plus IPO of microbiome company Seres Therapeutics, your wait should be over before the weekend comes. If you’re a patient with a terrible bacterial infection in your gut anticipating Seres’ lead product, you’ll probably have to wait at least a couple more years. But that doesn’t mean … Continue reading “On Eve of Seres IPO, A Rival Nonprofit Microbiome Treatment Expands”
MIT Startup Celect Gets $5M to Apply Predictive Analytics to Retail
By now you’re used to the idea that companies are trying to predict your every move when you shop online. But how about in the real world? Boston-based startup Celect has a new approach to understanding and predicting customer behavior in brick-and-mortar stores. Now the company has raised a $5 million Series A round led … Continue reading “MIT Startup Celect Gets $5M to Apply Predictive Analytics to Retail”
Genzyme Vet McGorry Steps in as New CEO of Harvard Apparatus
James McGorry, a 12-year veteran of Genzyme, has been named the new CEO of Holliston, MA-based Harvard Apparatus Regenerative Technology (NASDAQ: [[ticker:HART]]). HART has been searching for a new CEO since founding executive David Green resigned in April, saying in a statement that “the time was right to bring in a new CEO who has … Continue reading “Genzyme Vet McGorry Steps in as New CEO of Harvard Apparatus”
Retooled Catabasis Cuts Price, Upsizes to Grab $60M in IPO
Catabasis Pharmaceuticals has done some strategic tinkering over the past few years, and the Cambridge, MA-based company did a bit more maneuvering on Wednesday to price its IPO. Catabasis is set to debut on the Nasdaq this morning after raising $60 million in an IPO. It had to sell more shares at a lower price … Continue reading “Retooled Catabasis Cuts Price, Upsizes to Grab $60M in IPO”
Eleven Bio CFO Perry Heads to Aegerion
Former Eleven Biotherapeutics (NASDAQ: [[ticker:EBIO]]) chief financial officer Gregory Perry has been named the new CFO of Aegerion Pharmaceuticals (NASDAQ: [[ticker:AEGR]]). Aside from Eleven Bio, Perry has also served in executive roles at InVivo Therapeutics, ImmunoGen, and Transkaryotic Therapeutics.
The Decade Of The Brain: 25 Years Later
My phone rang late in the day on a pleasant fall afternoon. It was a close friend and business associate of mine and, because we talk often enough about a whole variety of things, I didn’t think for a moment about not answering. I rarely talk about my days as a practicing physician, and it’s … Continue reading “The Decade Of The Brain: 25 Years Later”
Tesora Secures $4,500,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a20a08ea-4624-489b-8e8e-25f6cdacb106 Date 6/25/2015 Company Name Tesora Mailing Address 125 CambridgePark Drive Cambridge, MA 02140 USA Company Description With Tesora, OpenStack administrators can go beyond compute and storage to offer their users a self-service, managed database service for MySQL and other leading databases. Website http://www.tesora.com Transaction Type Venture Equity Transaction Amount $4,500,000 Transaction … Continue reading “Tesora Secures $4,500,000 New Round”
Extreme Reach Secures $56,532,353 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=003b2aef-3c11-4c83-b243-47dfa44962db Date 6/25/2015 Company Name Extreme Reach Mailing Address 75 2nd Avenue Needham, MA 02494 USA Company Description Our video advertising technology platform enables advertisers and agencies to manage, execute and track video campaigns across all video mediums (broadcast, cable, online publishing, mobile, VOD). Website http://www.extremereach.com Transaction Type Venture Equity Transaction Amount … Continue reading “Extreme Reach Secures $56,532,353 New Financing”
BitSight Technologies Garners $23,000,000 Series B Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2bc1b200-d560-4f9e-910e-7410d7e07975 Date 6/25/2015 Company Name BitSight Technologies Mailing Address 125 Cambridge Park Drive Cambridge, MA 02140 USA Company Description Our empirical, data-driven risk assessments provide organizations with the insight they need to proactively identify, quantify, and mitigate risk. Website http://www.bitsighttech.com Transaction Type Venture Equity Transaction Amount $23,000,000 Transaction Round Series B Proceeds … Continue reading “BitSight Technologies Garners $23,000,000 Series B Financing Round”
SQZ Biotech Secures $5,000,000 Series A Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=776cc9b8-e899-49f4-ab32-7af4e1326b3e Date 6/25/2015 Company Name SQZ Biotech Mailing Address 100 Morrissey Blvd. Boston, MA 02125 USA Company Description Many promising therapeutic modalities have limited clinical efficacy due to the challenges of delivering molecules into cells. SQZ Biotech seeks to address this fundamental problem by developing its CellSqueeze platform for use in drug … Continue reading “SQZ Biotech Secures $5,000,000 Series A Round”
7AC Technologies Receives $4,926,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=136641f4-8c2f-4d3b-82b8-cfbe113cd4d7 Date 6/25/2015 Company Name 7AC Technologies Mailing Address 100 Cummings Center Beverly, MA 01915 USA Company Description 7AC Technologies, Inc. develops revolutionary Ultra Efficient Liquid Desiccant HVAC systems for Commercial and Industrial (C&I) buildings delivering a 50%+ reduction in energy costs over conventional HVAC units. Website http://www.7actech.com Transaction Type Venture Equity … Continue reading “7AC Technologies Receives $4,926,000 New Round”
Tesora Takes In $4.5M to Advance Database as a Service
A local tech startup has some new money to push its vision of making database-as-a-service useful for enterprise customers. Cambridge, MA-based Tesora, formerly known as ParElastic, says it has raised $4.5 million from new investor Rho Canada Ventures and previous investors, including General Catalyst, CommonAngels Ventures, and Point Judith Capital. The company now has raised … Continue reading “Tesora Takes In $4.5M to Advance Database as a Service”
With Fresh Eyes, A Return To Biotech’s City Within A City
What a difference a decade makes. I left the Boston/Cambridge biotech community in 2005, when it was a lot sleepier and a lot smaller. Focused densely within just a few dozen blocks around the MIT campus, nascent successes like Vertex stood shoulder to shoulder with more established companies that were only older by single-digit years. … Continue reading “With Fresh Eyes, A Return To Biotech’s City Within A City”
SQZ Biotech Shifts to Therapy Development with $5M Series A
Scientists lucky enough to develop a breakthrough technology often still face the difficult task of commercializing the product. Do they license the technology to researchers? Do they develop it themselves, or maybe instead find a bigger, more experienced partner? SQZ Biotech finds itself today in such a time of transition. The Boston startup, founded through … Continue reading “SQZ Biotech Shifts to Therapy Development with $5M Series A”
Introducing Exome, Xconomy’s New Home For Biotech and Health Coverage
By now you’ve had a day or two to meet Exome, Xconomy’s new place for all things life sciences, health, and biotech, which launched Monday. Let me amend that. Some things are new, which I’ll get to in a moment, but some things remain the same: the reporting and analysis you expect from me, Ben … Continue reading “Introducing Exome, Xconomy’s New Home For Biotech and Health Coverage”
U.S. IPO Activity Loses Steam to PE Deals in First Half of 2015
In the strange times category of today’s innovation news, a preview of IPO activity through the first half of 2015 suggests that market bubbles don’t always rise. In fact, the total number of IPO deals and proceeds actually sank through the first half of 2015, with 101 IPOs raising total proceeds of $19.7 billion, according … Continue reading “U.S. IPO Activity Loses Steam to PE Deals in First Half of 2015”
Starr Out, Tessier-Lavigne in as Agios Chairman
Third Rock Ventures partner Kevin Starr decided not to stand for re-election as the chairman of Cambridge, MA-based Agios Pharmaceuticals (NASDAQ: [[ticker:AGIO]]), a company he helped found in 2007. At a shareholder meeting today, Rockefeller University president Marc Tessier-Lavigne was named Starr’s replacement. Tessier-Lavigne was already chairing Agios’s compensation committee. He’s also the chairman of … Continue reading “Starr Out, Tessier-Lavigne in as Agios Chairman”